ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 571

Unraveling the Familial Tendency for Ankylosing Spondylitis in Korea

Hye Won Kim1, Hye Rim Choe2, Won Ik Chang3, Yong-Gil Kim4, Bin Yoo4, Jin Wook Hur1, Tae-Hwan Kim5, Sungim Lee6 and Eun Young Lee7, 1Division of Rheumatology, Department of Internal Medicine, Eulji University of Medicine, Eulji General Hospital, Seoul, South Korea, 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea, 3Seoul National University College of Medicine, Seoul, South Korea, 4Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 5Division of Rheumatology, Department of Internal Medicine, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 6Department of Applied Statistics, Dankook University, Yongin, South Korea, 7Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), family studies and risk assessment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment I

Session Type: Abstract Submissions (ACR)

Background/Purpose : Despite of the evidence of familial aggregation of ankylosing spondylitis (AS), familial tendencies are not fully explored. The purpose of this study was to examine the recurrence risk (RR) ratios in different degrees of relatives for Korean AS patients.

Methods: 526 consecutive unrelated AS probands (101 female, 425 male, mean age 35.5 years, mean disease duration 12.3 years, 88.7% HLA-B27 positive) fulfilling the modified New York criteria were face-to-face-interviewed by physicians, with elaborated questionnaire to investigate AS in other family members by the same criteria. A total of 12,051 relatives (2284, 5342 and 4425 for first, second and third-degree relatives (TDR), respectively) were included. The RR ratios for different degrees of relatives were elicited and subsequently stratified by gender and HLA-B27 status. The prevalence of AS among Korean in 2013 was estimated by the Korean National Health Insurance Service at 0.07%.

Results: The RR ratio was 53.8 for first-degree relatives (FDR) followed by 10.8, 9.0 for second-degree relatives (SDR) and TDR, respectively, indicating strictly decreasing in familiality. Among FDRs, siblings were more frequently affected than offspring or parents. For male probands, the overall RR ratio for FDR was 55.5, and 65 for female, implying higher familiality of female over male. Remarkably, all of affected SDRs and beyond were relatives of HLA-B27 positive probands.

Conclusion: We demonstrated strongest familiality of AS in FDRs, particularly in siblings. Despite of similar sharp decline pattern of familiality beyond SDR, lower RR ratio in FDR in our study, compared to previous Caucasian reports, indicates ethnic difference in inheritance of the same disease. This study suggests familial tendency for AS can be explained by degrees of relationship, gender and HLA-B27, warranting further studies.


Disclosure:

H. W. Kim,
None;

H. R. Choe,
None;

W. I. Chang,
None;

Y. G. Kim,
None;

B. Yoo,
None;

J. W. Hur,
None;

T. H. Kim,
None;

S. Lee,
None;

E. Y. Lee,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/unraveling-the-familial-tendency-for-ankylosing-spondylitis-in-korea/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology